ZA9510671B - Thienopyridone - Google Patents

Thienopyridone

Info

Publication number
ZA9510671B
ZA9510671B ZA9510671A ZA9510671A ZA9510671B ZA 9510671 B ZA9510671 B ZA 9510671B ZA 9510671 A ZA9510671 A ZA 9510671A ZA 9510671 A ZA9510671 A ZA 9510671A ZA 9510671 B ZA9510671 B ZA 9510671B
Authority
ZA
South Africa
Prior art keywords
thienopyridone
Prior art date
Application number
ZA9510671A
Other languages
English (en)
Inventor
Rudolf Gottschlich
Joachim Leibrock
Christian Noe
Michael Berger
Hans-Peter Buchstaller
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA9510671B publication Critical patent/ZA9510671B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9510671A 1994-12-15 1995-12-14 Thienopyridone ZA9510671B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4444815A DE4444815A1 (de) 1994-12-15 1994-12-15 Thienopyridone
CN95120906A CN1133843A (zh) 1994-12-15 1995-12-19 噻吩并吡啶酮

Publications (1)

Publication Number Publication Date
ZA9510671B true ZA9510671B (en) 1996-07-11

Family

ID=37698014

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510671A ZA9510671B (en) 1994-12-15 1995-12-14 Thienopyridone

Country Status (17)

Country Link
US (1) US5602144A (ja)
EP (1) EP0717044A1 (ja)
JP (1) JPH08239387A (ja)
CN (1) CN1133843A (ja)
AU (1) AU703603B2 (ja)
BR (1) BR9505899A (ja)
CA (1) CA2165129A1 (ja)
CZ (1) CZ319395A3 (ja)
DE (1) DE4444815A1 (ja)
FI (1) FI956024A (ja)
HU (1) HUT75091A (ja)
NO (1) NO955075L (ja)
PL (1) PL311838A1 (ja)
RU (1) RU2155766C2 (ja)
SK (1) SK157195A3 (ja)
TR (1) TR199501562A2 (ja)
ZA (1) ZA9510671B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL364388A1 (en) * 2001-03-14 2004-12-13 Grünenthal GmbH Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
GB0124848D0 (en) * 2001-10-16 2001-12-05 Celltech R&D Ltd Chemical compounds
US7119205B2 (en) * 2003-05-16 2006-10-10 Abbott Laboratories Thienopyridones as AMPK activators for the treatment of diabetes and obesity
EP1754483A1 (en) * 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
PL2262500T3 (pl) 2008-04-11 2016-09-30 Pochodne tienopirydonowe jako aktywatory kinazy białkowej aktywowanej przez amp (ampk)
AU2009243811B2 (en) * 2008-05-05 2014-04-10 Merck Patent Gmbh Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
AU2009289784B2 (en) * 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
EP2679591A1 (en) 2012-06-29 2014-01-01 Poxel Thienopyridone derivatives useful as activators of AMPK

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626418B2 (en) * 1989-05-16 1992-07-30 Merrell Pharmaceuticals Inc. Excitatory amino acid antagonists
US5026700A (en) * 1989-05-16 1991-06-25 Merrell Dow Pharmaceuticals Certain quinolines and thienopyridines as excitatory amino acid antagonists
US5112821A (en) * 1989-05-16 1992-05-12 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists which are certain thienopyridives
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
US5129864A (en) * 1991-02-27 1992-07-14 Dayco Products, Inc. Tensioner for a power transmission belt and method of making the same
US5155115A (en) * 1991-03-12 1992-10-13 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
US5219864A (en) * 1991-03-12 1993-06-15 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
JPH05134373A (ja) * 1991-11-14 1993-05-28 Konica Corp 新規な写真用カプラー
DE4227747A1 (de) * 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
HUT75091A (en) 1997-04-28
HU9503582D0 (en) 1996-02-28
PL311838A1 (en) 1996-06-24
AU4029295A (en) 1996-06-20
NO955075L (no) 1996-06-17
JPH08239387A (ja) 1996-09-17
CN1133843A (zh) 1996-10-23
US5602144A (en) 1997-02-11
AU703603B2 (en) 1999-03-25
BR9505899A (pt) 1998-01-06
CZ319395A3 (en) 1996-07-17
FI956024A (fi) 1996-06-16
FI956024A0 (fi) 1995-12-14
NO955075D0 (no) 1995-12-14
SK157195A3 (en) 1996-07-03
DE4444815A1 (de) 1996-06-20
TR199501562A2 (tr) 1996-07-21
RU2155766C2 (ru) 2000-09-10
EP0717044A1 (de) 1996-06-19
CA2165129A1 (en) 1996-06-16

Similar Documents

Publication Publication Date Title
GB2294043B (en) Bisresorcinyltriazines
DE69512030D1 (en) Cerebral-dilator
GB2293823B (en) 2-Hydroxyphenyltriazines
EP0696731A3 (en) Cytoanalyzer
DE59503739D1 (en) Polymer-sensor
DE69502271D1 (en) Afterabtrennung
DE69511086D1 (en) Pyrimidinderivate
DE69429543D1 (en) Koagulationszange
DE69504528D1 (en) Quenchkühler
GB2296033B (en) Handleset
DE59503634D1 (en) Friercontainer
EP0701109A3 (de) Wasserzähler
GB2296715B (en) Bisallyloxyimides
DE69512382D1 (en) Deodorierte thermoplaste
DE59509661D1 (en) Heterocyclylbenzonitrile
EP0711710A3 (de) Palettenbehälter
DE69517886D1 (en) Spiropyranverbindung
DE69517588D1 (en) Gekühlter transportcontainer
ZA9510671B (en) Thienopyridone
AU122938S (en) Breadbox
GB2289889B (en) Spiles
DE69508761D1 (en) Haloalkylierungsverfahren
DE69506730D1 (en) Differentialer antriebsmechanismus
DE69527047D1 (en) Bisazoverbindung
DE59508136D1 (en) Phenylthio-oxazolin-derivate